25 related articles for article (PubMed ID: 9539573)
1. Novel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinoma.
Xu S; Tang YY; Yu YX; Yun Q; Yang JP; Zhang H; Peng Q; Sun X; Yang LL; Fu S; Wu JB
Drug Deliv; 2017 Nov; 24(1):1139-1147. PubMed ID: 28797171
[TBL] [Abstract][Full Text] [Related]
2. Exercise and Prebiotic Fiber Provide Gut Microbiota-Driven Benefit in a Survivor to Germ-Free Mouse Translational Model of Breast Cancer.
Sampsell K; Wang W; Ohland C; Mager LF; Pett N; Lowry DE; Sales KM; McNeely ML; McCoy KD; Culos-Reed SN; Reimer RA
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681702
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy.
Nawara HM; Afify SM; Hassan G; Zahra MH; Seno A; Seno M
Biomedicines; 2021 May; 9(5):. PubMed ID: 34063205
[TBL] [Abstract][Full Text] [Related]
4. Combination Radioimmunotherapy Strategies for Solid Tumors.
Zaheer J; Kim H; Lee YJ; Kim JS; Lim SM
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717302
[TBL] [Abstract][Full Text] [Related]
5. AIEgen-based theranostic system: targeted imaging of cancer cells and adjuvant amplification of antitumor efficacy of paclitaxel.
Chen C; Song Z; Zheng X; He Z; Liu B; Huang X; Kong D; Ding D; Tang BZ
Chem Sci; 2017 Mar; 8(3):2191-2198. PubMed ID: 28507673
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy.
Barbuti AM; Chen ZS
Cancers (Basel); 2015 Dec; 7(4):2360-71. PubMed ID: 26633515
[TBL] [Abstract][Full Text] [Related]
7. NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel.
Negishi T; Koizumi F; Uchino H; Kuroda J; Kawaguchi T; Naito S; Matsumura Y
Br J Cancer; 2006 Sep; 95(5):601-6. PubMed ID: 16909136
[TBL] [Abstract][Full Text] [Related]
8. The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation.
Danielsson A; Karlsson E; Delle U; Helou K; Mercke C
J Cancer Res Clin Oncol; 2005 Jul; 131(7):459-67. PubMed ID: 15776273
[TBL] [Abstract][Full Text] [Related]
9. [Combined radiochemotherapy of non-small-cell bronchial carcinoma with taxol].
Willner J; Flentje M
Strahlenther Onkol; 1999 Oct; 175 Suppl 3():14-9. PubMed ID: 10554640
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma.
Milas L; Saito Y; Hunter N; Milross CG; Mason KA
Radiother Oncol; 1996 Aug; 40(2):163-70. PubMed ID: 8884971
[TBL] [Abstract][Full Text] [Related]
11. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
Choy H; Yee L; Cole BF
Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of radiation response by paclitaxel in mice according to different treatment schedules.
Cividalli A; Arcangeli G; Cruciani G; Livdi E; Cordelli E; Danesi DT
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1163-70. PubMed ID: 9539573
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia enhances the response of paclitaxel and radiation in a mouse adenocarcinoma.
Cividalli A; Cruciani G; Livdi E; Pasqualetti P; Tirindelli Danesi D
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):407-12. PubMed ID: 10760437
[TBL] [Abstract][Full Text] [Related]
14. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Murata R; Tsujitani M; Horsman MR
Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule.
Cividalli A; Ceciarelli F; Livdi E; Altavista P; Cruciani G; Marchetti P; Danesi DT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1092-8. PubMed ID: 11958906
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
